Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis

doi:10.3748/wjg.v20.i45.17206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 45

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7380)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

559

WORD

234

HTML

4411

Figures (1-7)

179

Tables (1-2)

147

Sum=5530

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

870

Download

980

Sum=1850

Dec 7, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Dec 7, 2014; 20(45): 17206-17217
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17206

Full Size Figure Download Figure

Figure 5 Microsphere embolization (90Y or DEB) vs conventional transarterial chemoembolization for treatment of patients with hepatocellular carcinoma in terms of tumor progression rate.

Citation: Ni JY, Xu LF, Wang WD, Sun HL, Chen YT. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(45): 17206-17217
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17206.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17206